A global phylogenetic analysis in order to determine the host species and geography dependent features present in the evolution of avian H9N2 influenza hemagglutinin-Reference-Cited by-同舟云学术

A global phylogenetic analysis in order to determine the host species and geography dependent features present in the evolution of avian H9N2 influenza hemagglutinin

Published:2014-10-30 Issue: Volume:2 Page:e655
ISSN:2167-8359
Container-title:PeerJ
language:en
Short-container-title:

Author:

Dalby Andrew R.¹,Iqbal Munir²

Affiliation:

1. Faculty of Science and Technology, University of Westminster, Westminster, UK

2. Avian Viral Diseases Programme, The Pirbright Institute, Compton Laboratory, Newbury, Berkshire, UK

Publisher

PeerJ

Subject

General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://peerj.com/articles/655.pdf

Reference70 articles.

1. Isolation and mutation trend analysis of influenza A virus subtype H9N2 in Egypt;Abdel-Moneim;Virology Journal,2012

2. Phylogenetic analysis of influenza A viruses of H9 haemagglutinin subtype;Banks;Avian Pathology,2000

3. Canalization of the evolutionary trajectory of the human influenza virus;Bedford;BMC Biology,2012

4. Flu surveillance lacking;Butler;Nature,2012

5. Avian influenza A (H9N2): computational molecular analysis and phylogenetic characterization of viral surface proteins isolated between 1997 and 2009 from the human population;Butt;Virology Journal,2010

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proposal for a Global Classification and Nomenclature System for A/H9 Influenza Viruses;Emerging Infectious Diseases;2024-08

2. Threat, challenges, and preparedness for future pandemics: A descriptive review of phylogenetic analysis based predictions;Infection, Genetics and Evolution;2022-03

3. Experimental Infection and In-Contact Transmission of H9N2 Avian Influenza Virus in Crows;Pathogens;2022-02-28

4. Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study;Journal of Experimental & Clinical Cancer Research;2020-12

5. Evaluating Trastuzumab in the treatment of HER2 positive breast cancer;HISTOL HISTOPATHOL;2020